Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L K Chan

Showing results (61-70 of 74) with videos related to

Pageof 8
Sort By:
Oral Oncology|February 18, 2014
The impact of dosimetric inadequacy on treatment outcome of nasopharyngeal carcinoma with IMRTWai Tong Ng, Michael C H Lee, Amy T Y Chang, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|March 18, 2014
Evolution of treatment for nasopharyngeal cancer--success and setback in the intensity-modulated radiotherapy eraAnne W M Lee, Wai Tong Ng, Lucy L K Chan, et al.
Head & Neck|November 30, 2016
Reirradiation with intensity-modulated radiotherapy for locally recurrent T3 to T4 nasopharyngeal carcinomaOscar S H Chan, Henry C K Sze, Michael C H Lee, et al.
Oral Oncology|September 28, 2014
Should all nasopharyngeal carcinoma with masticator space involvement be staged as T4?Henry Sze, Lucy L K Chan, W T Ng, et al.
Hong Kong Medical Journal = Xianggang Yi Xue Za Zhi|December 13, 2005
Magnetic resonance venogram of intravenous leiomyomatosisT K K Lai, H Y H Huang, R Y Y Chan, et al.
International Journal of Radiation Oncology, Biology, Physics|February 8, 2018
Prospective, Multicenter, Phase 2 Trial of Induction Chemotherapy Followed by Bio-Chemoradiotherapy for Locally Advanced Recurrent Nasopharyngeal CarcinomaWai-Tong Ng, Roger K C Ngan, Dora L W Kwong, et al.
Cancer|June 30, 2017
A multicenter, phase 3, randomized trial of concurrent chemoradiotherapy plus adjuvant chemotherapy versus radiotherapy alone in patients with regionally advanced nasopharyngeal carcinoma: 10-year outcomes for efficacy and toxicityAnne W M Lee, Stewart Y Tung, Wai Tong Ng, et al.
Cancer|December 23, 2014
Preliminary results of trial NPC-0501 evaluating the therapeutic gain by changing from concurrent-adjuvant to induction-concurrent chemoradiotherapy, changing from fluorouracil to capecitabine, and changing from conventional to accelerated radiotherapy fractionation in patients with locoregionally advanced nasopharyngeal carcinomaAnne W M Lee, Roger K C Ngan, Stewart Y Tung, et al.
European Journal of Cancer (Oxford, England : 1990)|November 30, 2010
Factors contributing to the efficacy of concurrent-adjuvant chemotherapy for locoregionally advanced nasopharyngeal carcinoma: combined analyses of NPC-9901 and NPC-9902 TrialsAnne W M Lee, Stewart Y Tung, Roger K C Ngan, et al.
International Journal of Radiation Oncology, Biology, Physics|June 11, 2018
Concurrent-Adjuvant Chemoradiation Therapy for Stage III-IVB Nasopharyngeal Carcinoma-Exploration for Achieving Optimal 10-Year Therapeutic RatioWai-Tong Ng, Stewart Y Tung, Victor Lee, et al.
Pageof 8

Showing results (61-70 of 74) with videos related to

Sort By:
Pageof 8
Oral Oncology|February 18, 2014
The impact of dosimetric inadequacy on treatment outcome of nasopharyngeal carcinoma with IMRTWai Tong Ng, Michael C H Lee, Amy T Y Chang, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|March 18, 2014
Evolution of treatment for nasopharyngeal cancer--success and setback in the intensity-modulated radiotherapy eraAnne W M Lee, Wai Tong Ng, Lucy L K Chan, et al.
Head & Neck|November 30, 2016
Reirradiation with intensity-modulated radiotherapy for locally recurrent T3 to T4 nasopharyngeal carcinomaOscar S H Chan, Henry C K Sze, Michael C H Lee, et al.
Oral Oncology|September 28, 2014
Should all nasopharyngeal carcinoma with masticator space involvement be staged as T4?Henry Sze, Lucy L K Chan, W T Ng, et al.
Hong Kong Medical Journal = Xianggang Yi Xue Za Zhi|December 13, 2005
Magnetic resonance venogram of intravenous leiomyomatosisT K K Lai, H Y H Huang, R Y Y Chan, et al.
International Journal of Radiation Oncology, Biology, Physics|February 8, 2018
Prospective, Multicenter, Phase 2 Trial of Induction Chemotherapy Followed by Bio-Chemoradiotherapy for Locally Advanced Recurrent Nasopharyngeal CarcinomaWai-Tong Ng, Roger K C Ngan, Dora L W Kwong, et al.
Cancer|June 30, 2017
A multicenter, phase 3, randomized trial of concurrent chemoradiotherapy plus adjuvant chemotherapy versus radiotherapy alone in patients with regionally advanced nasopharyngeal carcinoma: 10-year outcomes for efficacy and toxicityAnne W M Lee, Stewart Y Tung, Wai Tong Ng, et al.
Cancer|December 23, 2014
Preliminary results of trial NPC-0501 evaluating the therapeutic gain by changing from concurrent-adjuvant to induction-concurrent chemoradiotherapy, changing from fluorouracil to capecitabine, and changing from conventional to accelerated radiotherapy fractionation in patients with locoregionally advanced nasopharyngeal carcinomaAnne W M Lee, Roger K C Ngan, Stewart Y Tung, et al.
European Journal of Cancer (Oxford, England : 1990)|November 30, 2010
Factors contributing to the efficacy of concurrent-adjuvant chemotherapy for locoregionally advanced nasopharyngeal carcinoma: combined analyses of NPC-9901 and NPC-9902 TrialsAnne W M Lee, Stewart Y Tung, Roger K C Ngan, et al.
International Journal of Radiation Oncology, Biology, Physics|June 11, 2018
Concurrent-Adjuvant Chemoradiation Therapy for Stage III-IVB Nasopharyngeal Carcinoma-Exploration for Achieving Optimal 10-Year Therapeutic RatioWai-Tong Ng, Stewart Y Tung, Victor Lee, et al.
Pageof 8